Nasal obstruction/severe mucus production · children with acute lower respiratory tract infections
Nasal prongs may leads to lower nasal obstruction/severe mucus production compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Nose ulceration or bleeding · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in nose ulceration or bleeding compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Fighting/discomfort in the first 24 hours · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in fighting/discomfort in the first 24 hours compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Death during treatment · children with acute lower respiratory tract infections
Nasal prongs showed no clear difference in death during treatment compared with nasopharyngeal catheter (low certainty).
1 finding from 1 review
Exacerbation of IBD · IBD patients
Etoricoxib showed no clear difference in exacerbation of IBD compared with placebo (low certainty).
1 finding from 1 review
Exacerbation of ulcerative colitis · Patients with quiescent ulcerative colitis
Celecoxib showed no clear difference in exacerbation of ulcerative colitis compared with placebo (low certainty).
1 finding from 1 review
GI adverse events · Patients with quiescent ulcerative colitis
Celecoxib showed no clear difference in GI adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Death at any time in trial period case mortality count · Patients with acute traumatic brain injury
The intervention probably leads to lower death at any time in trial period case mortality count (moderate certainty).
1 finding from 1 review
Intervention not reported
Favourable outcome GOS <9 or similar · Patients with acute traumatic brain injury
The intervention showed no clear difference in favourable outcome GOS <9 or similar; GRADE not reported.
1 finding from 1 review
Intervention not reported
Mean improvement in pure‐tone average hearing threshold across all frequencies Decibels Scale from: 0 to 120 · patients with idiopathic sudden sensorineural hearing loss or tinnitus
1 finding from 1 review
Intervention not reported
More than 50% improvement in pure‐tone average threshold Risk ratio · patients with idiopathic sudden sensorineural hearing loss or tinnitus
The intervention showed no clear difference in more than 50% improvement in pure‐tone average threshold Risk ratio (moderate certainty).
1 finding from 1 review
Intervention not reported
More than 25% improvement in pure‐tone average threshold Risk ratio · patients with idiopathic sudden sensorineural hearing loss or tinnitus
The intervention probably leads to higher more than 25% improvement in pure‐tone average threshold Risk ratio (moderate certainty).
1 finding from 1 review
change in respiratory distress score at 30 minutes Scale from: 0 to 13. · patients with acute bronchiolitis in children up to three years of age
2 findings from 1 review
change in respiratory distress score at 30 minutes Scale from: 0 to 13. · patients with acute bronchiolitis in children up to three years of age
2 findings from 1 review